Atom Investors LP Sells 8,543 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Atom Investors LP decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 27.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,741 shares of the company's stock after selling 8,543 shares during the quarter. Atom Investors LP's holdings in Henry Schein were worth $1,658,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HSIC. Cromwell Holdings LLC grew its stake in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock valued at $26,000 after buying an additional 170 shares during the last quarter. Summit Securities Group LLC acquired a new stake in Henry Schein during the 2nd quarter worth approximately $31,000. Blue Trust Inc. boosted its stake in Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company's stock valued at $60,000 after purchasing an additional 475 shares during the period. Farther Finance Advisors LLC increased its position in Henry Schein by 58.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock worth $68,000 after buying an additional 346 shares during the period. Finally, Mather Group LLC. lifted its holdings in shares of Henry Schein by 16.8% during the second quarter. Mather Group LLC. now owns 1,502 shares of the company's stock worth $96,000 after buying an additional 216 shares in the last quarter. 96.62% of the stock is owned by institutional investors.

Insider Transactions at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the business's stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares of the company's stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research firms recently commented on HSIC. Evercore ISI raised their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 8th. StockNews.com upgraded Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. JPMorgan Chase & Co. dropped their price objective on Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a report on Monday, August 12th. Barrington Research reissued an "outperform" rating and set a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. Finally, Robert W. Baird dropped their price target on Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a research note on Wednesday, August 7th. Six investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $79.38.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded down $0.78 during mid-day trading on Tuesday, hitting $75.72. 283,265 shares of the stock traded hands, compared to its average volume of 1,392,805. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The firm has a 50 day simple moving average of $71.57 and a two-hundred day simple moving average of $69.88. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a market cap of $9.44 billion, a PE ratio of 31.48, a price-to-earnings-growth ratio of 2.21 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same period in the previous year, the business posted $1.32 earnings per share. The business's quarterly revenue was up .4% compared to the same quarter last year. As a group, equities research analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.